Scientific Concepts & Research Design Flashcards

In the hierarchy of evidence for clinical research, which of the following study designs provides the most robust and reliable evidence for the efficacy of a new intervention?

Answer: Systematic review or meta-analysis of randomized controlled trials

A systematic review or meta-analysis sits at the pinnacle of the evidence hierarchy. It synthesizes the results of multiple high-quality randomized controlled trials (RCTs), providing a more comprehensive and statistically powerful conclusion than any single study. While RCTs themselves are strong, a meta-analysis combines their data, increasing the overall sample size and reducing the likelihood of random error, thus offering the highest level of evidence.

A clinical trial is designed where neither the participants nor the investigators interacting with them know who is receiving the experimental drug and who is receiving the placebo. This type of study is best described as:

Answer: A double-blind study

A double-blind study is a design in which neither the participants nor the investigators (including study staff who interact with participants) are aware of the treatment allocation. This method is crucial for minimizing bias, as knowledge of the treatment could influence participant reporting, staff administration of the intervention, or outcome assessment.

A research coordinator is working on a study that investigates the association between a specific dietary habit (exposure) and the development of a rare disease. The study identifies individuals who already have the disease (cases) and a similar group without the disease (controls), and then looks back in time to compare their past dietary habits. What is this type of observational study design called?

Answer: Case-control study

This scenario describes a case-control study. This is a retrospective observational design where the researcher begins with the outcome (the presence or absence of the disease) and then looks backward to ascertain differences in exposure between the two groups. It is particularly useful for studying rare diseases or outcomes with long latency periods.

Which of the following is the primary purpose of randomization in a clinical trial?

Answer: To prevent selection bias by creating comparable study groups.

The primary purpose of randomization is to minimize selection bias by ensuring that each participant has an equal chance of being assigned to any of the treatment groups. This process helps to create groups that are comparable in terms of both known and unknown prognostic factors, so that any observed differences in outcomes can be attributed to the intervention being studied rather than pre-existing differences between the groups.

In a clinical trial, a p-value of <0.05 is typically interpreted as:

Answer: The observed result is statistically significant, and the null hypothesis is rejected.

A p-value represents the probability of observing the study results (or more extreme results) if the null hypothesis were true. A p-value of less than 0.05 is a conventional threshold used to declare a result 'statistically significant,' meaning the observed difference is unlikely to be due to chance alone, leading to the rejection of the null hypothesis. It does not, however, indicate the size or clinical importance of the effect.

A study is designed to test a new antihypertensive drug. During the study, the investigators provide more frequent follow-up and encouragement to the participants in the active treatment group compared to the placebo group. This is an example of what type of bias?

Answer: Performance bias

Performance bias occurs when there are systematic differences in the care provided to the comparison groups, other than the intervention being evaluated. In this scenario, the differential treatment of the groups (more attention to the active group) could influence the outcome independently of the drug's effect. Blinding of investigators and participants is the primary method to prevent this type of bias.